ILF3 and urinary bladder carcinoma: In recent years, NF90 has been found to be differentially expressed in several types of cancers such as ovarian, breast, cervical, hepatocellular and nasopharyngeal carcinomas, leukemia, and bladder cancer [22,37,42,43,44].